Follow
Anthony Maxwell
Anthony Maxwell
Project Leader, John Innes Centre
Verified email at jic.ac.uk - Homepage
Title
Cited by
Cited by
Year
DNA gyrase: structure and function
RJ Reece, A Maxwell
Critical reviews in biochemistry and molecular biology 26 (3-4), 335-375, 1991
8721991
Crystal structure of an N-terminal fragment of the DNA gyrase B protein
DB Wigley, GJ Davies, EJ Dodson, A Maxwell, G Dodson
Nature 351 (6328), 624-629, 1991
6681991
Exploiting bacterial DNA gyrase as a drug target: current state and perspectives
F Collin, S Karkare, A Maxwell
Applied microbiology and biotechnology 92, 479-497, 2011
5952011
Crystal structure of the breakage–reunion domain of DNA gyrase
JHM Cabral, AP Jackson, CV Smith, N Shikotra, A Maxwell, ...
Nature 388 (6645), 903-906, 1997
5921997
DNA topology
AD Bates, A Maxwell
Oxford University Press, USA, 2005
5712005
DNA gyrase as a drug target
A Maxwell
Trends in microbiology 5 (3), 102-109, 1997
4531997
The 43-kilodalton N-terminal fragment of the DNA gyrase B protein hydrolyzes ATP and binds coumarin drugs
JA Ali, AP Jackson, AJ Howells, A Maxwell
Biochemistry 32 (10), 2717-2724, 1993
4231993
The nature of inhibition of DNA gyrase by the coumarins and the cyclothialidines revealed by X‐ray crystallography.
RJ Lewis, OM Singh, CV Smith, T Skarzynski, A Maxwell, AJ Wonacott, ...
The EMBO journal 15 (6), 1412-1420, 1996
3981996
A fluoroquinolone resistance protein from Mycobacterium tuberculosis that mimics DNA
SS Hegde, MW Vetting, SL Roderick, LA Mitchenall, A Maxwell, HE Takiff, ...
Science 308 (5727), 1480-1483, 2005
3642005
A single point mutation in the DNA gyrase A protein greatly reduces binding of fluoroquinolones to the gyrase-DNA complex
CJ Willmott, A Maxwell
Antimicrobial agents and chemotherapy 37 (1), 126-127, 1993
3601993
Mechanistic aspects of DNA topoisomerases
A Maxwell, M Gellert
Advances in protein chemistry 38, 69-107, 1986
3431986
The interaction between coumarin drugs and DNA gyrase
A Maxwell
Molecular microbiology 9 (4), 681-686, 1993
3351993
The ATP-binding site of type II topoisomerases as a target for antibacterial drugs
A Maxwell, DM Lawson
Current topics in medicinal chemistry 3 (3), 283-303, 2003
3112003
Novobiocin: redesigning a DNA gyrase inhibitor for selective inhibition of hsp90
JA Burlison, L Neckers, AB Smith, A Maxwell, BSJ Blagg
Journal of the American Chemical Society 128 (48), 15529-15536, 2006
2812006
Arabidopsis SPO11‐2 functions with SPO11‐1 in meiotic recombination
NJ Stacey, T Kuromori, Y Azumi, G Roberts, C Breuer, T Wada, A Maxwell, ...
The Plant Journal 48 (2), 206-216, 2006
2642006
Interaction between DNA Gyrase and Quinolones: Effects of Alanine Mutations at GyrA Subunit Residues Ser83and Asp87
FM Barnard, A Maxwell
Antimicrobial agents and chemotherapy 45 (7), 1994-2000, 2001
2522001
DNA topology
AD Bates, A Maxwell
IRL Press at Oxford University Press, 1993
2311993
Quinolones: mechanism, lethality and their contributions to antibiotic resistance
NG Bush, I Diez-Santos, LR Abbott, A Maxwell
Molecules 25 (23), 5662, 2020
2282020
The molecular basis of quinolone action
A MAXWELL
Journal of Antimicrobial Chemotherapy 30 (4), 409-414, 1992
2211992
The interaction of coumarin antibiotics with fragments of the DNA gyrase B protein
NA Gormley, G Orphanides, A Meyer, PM Cullis, A Maxwell
Biochemistry 35 (15), 5083-5092, 1996
2191996
The system can't perform the operation now. Try again later.
Articles 1–20